Lv1
30 积分 2025-08-20 加入
Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway
10小时前
待确认
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
15天前
已完结
MRI‐Based Machine Learning Radiomics for Preoperative Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Bladder Carcinoma
22天前
已完结
Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis
1个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
1个月前
已完结
Decoding the Role of SLC25A5 in Osteosarcoma Drug Resistance and CD8+ T Cell Exhaustion: The Therapeutic Potential of Phyllanthin
3个月前
已完结
A noncanonical cytoplasmic role for BUB1 in restraining DNA damage-induced dsRNA accumulation and sensing within stress granules
4个月前
已完结
皖公网安备34019202002308
